MSI-H And dMMR Global Market Report 2025

Name: MSI-H And dMMR Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Download Sample Buy Report

Global MSI-H And dMMR Market Report 2025

MSI-H And dMMR Global Market Report 2025 - By Treatment Type (Immune Checkpoint Inhibitors (ICIs), Combination Therapy), By Indication (Endometrial, Gastric, Colorectal Cancer, Small Intestine Cancer, Cervical Cancer, Other Indications), By Stage (Early Stages, Advanced Stages), By End User (Hospitals, Oncology Clinics, Research Institutions, Homecare) - Market Size, Trends, And Global Forecast 2025-2034

MSI-H And dMMR Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : June 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

MSI-H And dMMR Global Market Report 2025

Proud Members Of

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under MSI-H And dMMR Market?

MSI-H (microsatellite instability-high) and dMMR (deficient mismatch repair) refer to genetic abnormalities where the DNA repair system fails to correct replication errors, leading to high mutation rates. These markers are commonly found in certain cancers, such as colorectal and endometrial. Tumors with MSI-H and dMMR often respond well to immunotherapy due to their high immunogenicity.

The main treatment types for MSI-H and dMMR include immune checkpoint inhibitors (ICIs) and combination therapies. Immune checkpoint inhibitors are drugs that enhance the immune system's ability to fight cancer by blocking proteins such as PD-1, PD-L1, or CTLA-4, which tumors use to suppress immune responses. These treatments are used across various indications, including endometrial cancer, gastric cancer, colorectal cancer, small intestine cancer, cervical cancer, and other indications, and are applicable across different cancer stages, including early stages and advanced stages. These therapies are administered in various settings, such as hospitals, oncology clinics, research institutions, and homecare environments.

MSI-H And dMMR Market Size and growth rate 2025 to 2029: Graph

What Is The MSI-H And dMMR Market Size 2025 And Growth Rate?

The MSI-H and dMMR market size has grown exponentially in recent years. It will grow from $6.15 billion in 2024 to $7.59 billion in 2025 at a compound annual growth rate (CAGR) of 23.3%. The growth in the historic period can be attributed to rising incidence of colorectal and endometrial cancers, expanded genetic screening programs, growing clinical adoption of MSI testing, increasing awareness of hereditary cancer syndromes, and a rise in liquid biopsy adoption.

What Is The MSI-H And dMMR Market Growth Forecast?

The MSI-H and dMMR market size is expected to see exponential growth in the next few years. It will grow to $17.40 billion in 2029 at a compound annual growth rate (CAGR) of 23.1%. The growth in the forecast period can be attributed to increasing demand for personalized cancer therapies, expanding applications of next-generation sequencing, rising healthcare expenditure in oncology, growing clinical trials for immune checkpoint inhibitors, and regulatory support for companion diagnostics. Major trends in the forecast period include the integration of artificial intelligence in diagnostic workflows, partnerships between pharma and diagnostic companies, the development of multiplex biomarker panels, advances in immunotherapy, and a shift toward pan-cancer biomarker testing.

Book your 30 minutes free consultation with our research experts

How Is The MSI-H And dMMR Market Segmented?

The MSI-H and dMMR market covered in this report is segmented –

1) By Treatment Type: Immune Checkpoint Inhibitors (ICIs), Combination Therapy

2) By Indication: Endometrial, Gastric, Colorectal Cancer, Small Intestine Cancer, Cervical Cancer, Other Indications

3) By Stage: Early Stages, Advanced Stages

4) By End User: Hospitals, Oncology Clinics, Research Institutions, Homecare

Subsegments:

1) By Immune Checkpoint Inhibitors (ICIs): Programmed Cell Death Protein 1 Inhibitors, Programmed Cell Death Ligand 1 Inhibitors, Cytotoxic T-Lymphocyte Antigen 4 Inhibitors

2) By Combination Therapy: Immune Checkpoint Inhibitor + Chemotherapy, Immune Checkpoint Inhibitor + Targeted Therapy, Immune Checkpoint Inhibitor + Radiation Therapy, Immune Checkpoint Inhibitor + Other Immunotherapies

What Is Driving The MSI-H And dMMR Market? Rising Prevalence Of Cancer Is Fueling The Market Due To Increasing Demand For Personalized Immunotherapy Approaches

The rising prevalence of cancer is expected to propel the growth of the MSI-H and dMMR market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The rising prevalence of cancer is primarily due to aging populations, as the risk of developing cancer increases significantly with age because of the cumulative effect of genetic mutations and prolonged exposure to risk factors over time. MSI-H and dMMR are used in cancer to identify tumors with high mutation rates due to defects in DNA repair mechanisms. These biomarkers help guide immunotherapy decisions, as such tumors are more likely to respond to immune checkpoint inhibitors, and they also provide insight into prognosis and potential genetic syndromes. For instance, in January 2024, according to the American Cancer Society, a US-based non-profit organization, in 2023, an estimated 1,958,310 new cancer cases and 609,820 cancer-related deaths were expected in the United States. These numbers are projected to rise in 2024, with approximately 2,001,140 new cancer cases and 611,720 deaths anticipated, highlighting a continuing increase in cancer incidence and mortality. Therefore, the rising prevalence of cancer is driving the growth of the MSI-H and dMMR market.

Who Are The Major Players In The Global MSI-H And dMMR Market?

Major companies operating in the MSI-H and dMMR market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis International AG, AstraZeneca PLC, Bristol-Myers Squibb Company, GSK plc., Takeda Pharmaceutical Company, Incyte Corporation, Exact Sciences Corp., BeiGene LTD., Summit Therapeutics Inc., Tempus Labs Inc., Guardant Health, NeoGenomics Laboratories Inc., Promega Corporation, Caris Life Sciences, and Owkin.

What Are The Key Trends Of The Global MSI-H And dMMR Market? Innovative Combination Therapies Transforming MSI-H And dMMR Cancer Treatment

Major companies operating in the MSI-H and dMMR market are focusing on developing innovative treatments, such as combination therapy, to enhance treatment efficacy and improve patient outcomes. Combination therapy for MSI-H and dMMR cancers involves using two or more treatment modalities, commonly immunotherapy agents such as checkpoint inhibitors or combining immunotherapy with chemotherapy, targeted therapy, or radiation. This approach aims to enhance treatment response, overcome resistance, and improve survival outcomes in patients with tumors that exhibit high microsatellite instability or deficient mismatch repair. For instance, in April 2025, Bristol-Myers Squibb Company, a US-based pharmaceutical company, received United States Food and Drug Administration (FDA) approval for the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) as a first-line treatment for metastatic colorectal cancer (mCRC) with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) features, further advancing treatment options for this challenging cancer subtype. This approval marks a significant milestone in the treatment of MSI-H and dMMR cancers, as it provides a new, effective therapeutic option that targets multiple pathways to improve patient survival and response rates, addressing the unmet medical needs in this patient population.

What Are Latest Mergers And Acquisitions In The MSI-H And dMMR Market? Owkin Inc. Partners With MSD To Enhance AI-Powered Digital Pathology Diagnostics For Cancer

In December 2023, Owkin Inc., a France-based company specializing in AI-driven drug discovery and precision medicine, partnered with Merck & Co. Inc. to develop AI-powered digital pathology diagnostics for cancer. This collaboration aims to enhance MSI-H testing rates across various cancer types in the EU market, including endometrial, gastric, small intestinal, and biliary cancers, by leveraging artificial intelligence to improve diagnostic accuracy, streamline laboratory workflows, and better match patients with appropriate treatments. Merck & Co. Inc. is a US-based pharmaceutical company that focuses on providing KEYTRUDA (pembrolizumab) for adult and pediatric patients with unresectable or metastatic microsatellite instability-high (MSI-H) cancer.

What Is The Regional Outlook For The Global MSI-H And dMMR Market?

North America was the largest region in the MSI-H and dMMR market in 2024. The regions covered in the MSI-H and dMMR market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the MSI-H and dMMR market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the MSI-H And dMMR Market?

The MSI-H and dMMR market consists of revenues earned by entities by providing services such as genetic and molecular diagnostic testing, personalized treatment planning, and immunotherapy administration. The market value includes the value of related goods sold by the service provider or included within the service offering. The MSI-H and dMMR market consists of sales of bispecific antibodies, monoclonal antibodies, and oncolytic virus therapy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the MSI-H And dMMR Industry?

The MSI-H and dMMR market research report is one of a series of new reports from The Business Research Company that provides MSI-H and dMMR market statistics, including MSI-H and dMMR industry global market size, regional shares, competitors with a MSI-H and dMMR market share, detailed MSI-H and dMMR market segments, market trends and opportunities, and any further data you may need to thrive in the MSI-H and dMMR industry. This MSI-H and dMMR market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

MSI H And dMMR Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$7.59 billion
Revenue Forecast In 2034	$17.40 billion
Growth Rate	CAGR of 23.1% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The MSI-H and dMMR market covered in this report is segmented – 1) By Treatment Type: Immune Checkpoint Inhibitors (ICIs), Combination Therapy 2) By Indication: Endometrial, Gastric, Colorectal Cancer, Small Intestine Cancer, Cervical Cancer, Other Indications 3) By Stage: Early Stages, Advanced Stages 4) By End User: Hospitals, Oncology Clinics, Research Institutions, Homecare Subsegments: 1) By Immune Checkpoint Inhibitors (ICIs): Programmed Cell Death Protein 1 Inhibitors, Programmed Cell Death Ligand 1 Inhibitors, Cytotoxic T-Lymphocyte Antigen 4 Inhibitors 2) By Combination Therapy: Immune Checkpoint Inhibitor + Chemotherapy, Immune Checkpoint Inhibitor + Targeted Therapy, Immune Checkpoint Inhibitor + Radiation Therapy, Immune Checkpoint Inhibitor + Other Immunotherapies
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis International AG, AstraZeneca PLC, Bristol-Myers Squibb Company, GSK plc., Takeda Pharmaceutical Company, Incyte Corporation, Exact Sciences Corp., BeiGene LTD., Summit Therapeutics Inc., Tempus Labs Inc., Guardant Health, NeoGenomics Laboratories Inc., Promega Corporation, Caris Life Sciences, and Owkin.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. MSI-H And dMMR Market Characteristics

3. MSI-H And dMMR Market Trends And Strategies

4. MSI-H And dMMR Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global MSI-H And dMMR Growth Analysis And Strategic Analysis Framework

5.1. Global MSI-H And dMMR PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global MSI-H And dMMR Market Growth Rate Analysis

5.4. Global MSI-H And dMMR Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global MSI-H And dMMR Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global MSI-H And dMMR Total Addressable Market (TAM)

6. MSI-H And dMMR Market Segmentation

6.1. Global MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immune Checkpoint Inhibitors (ICIs)

Combination Therapy

6.2. Global MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Endometrial

Gastric

Colorectal Cancer

Small Intestine Cancer

Cervical Cancer

Other Indications

6.3. Global MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Early Stages

Advanced Stages

6.4. Global MSI-H And dMMR Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Oncology Clinics

Research Institutions

Homecare

6.5. Global MSI-H And dMMR Market, Sub-Segmentation Of Immune Checkpoint Inhibitors (ICIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Programmed Cell Death Protein 1 Inhibitors

Programmed Cell Death Ligand 1 Inhibitors

Cytotoxic T-Lymphocyte Antigen 4 Inhibitors

6.6. Global MSI-H And dMMR Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immune Checkpoint Inhibitor + Chemotherapy

Immune Checkpoint Inhibitor + Targeted Therapy

Immune Checkpoint Inhibitor + Radiation Therapy

Immune Checkpoint Inhibitor + Other Immunotherapies

7. MSI-H And dMMR Market Regional And Country Analysis

7.1. Global MSI-H And dMMR Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global MSI-H And dMMR Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific MSI-H And dMMR Market

8.1. Asia-Pacific MSI-H And dMMR Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China MSI-H And dMMR Market

9.1. China MSI-H And dMMR Market Overview

9.2. China MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India MSI-H And dMMR Market

10.1. India MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan MSI-H And dMMR Market

11.1. Japan MSI-H And dMMR Market Overview

11.2. Japan MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia MSI-H And dMMR Market

12.1. Australia MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia MSI-H And dMMR Market

13.1. Indonesia MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea MSI-H And dMMR Market

14.1. South Korea MSI-H And dMMR Market Overview

14.2. South Korea MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe MSI-H And dMMR Market

15.1. Western Europe MSI-H And dMMR Market Overview

15.2. Western Europe MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK MSI-H And dMMR Market

16.1. UK MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany MSI-H And dMMR Market

17.1. Germany MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France MSI-H And dMMR Market

18.1. France MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy MSI-H And dMMR Market

19.1. Italy MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain MSI-H And dMMR Market

20.1. Spain MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe MSI-H And dMMR Market

21.1. Eastern Europe MSI-H And dMMR Market Overview

21.2. Eastern Europe MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia MSI-H And dMMR Market

22.1. Russia MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America MSI-H And dMMR Market

23.1. North America MSI-H And dMMR Market Overview

23.2. North America MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA MSI-H And dMMR Market

24.1. USA MSI-H And dMMR Market Overview

24.2. USA MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada MSI-H And dMMR Market

25.1. Canada MSI-H And dMMR Market Overview

25.2. Canada MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America MSI-H And dMMR Market

26.1. South America MSI-H And dMMR Market Overview

26.2. South America MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil MSI-H And dMMR Market

27.1. Brazil MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East MSI-H And dMMR Market

28.1. Middle East MSI-H And dMMR Market Overview

28.2. Middle East MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa MSI-H And dMMR Market

29.1. Africa MSI-H And dMMR Market Overview

29.2. Africa MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. MSI-H And dMMR Market Competitive Landscape And Company Profiles

30.1. MSI-H And dMMR Market Competitive Landscape

30.2. MSI-H And dMMR Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. MSI-H And dMMR Market Other Major And Innovative Companies

31.1. Novartis International AG

31.2. AstraZeneca PLC

31.3. Bristol-Myers Squibb Company

31.4. GSK plc.

31.5. Takeda Pharmaceutical Company

31.6. Incyte Corporation

31.7. Exact Sciences Corp.

31.8. BeiGene LTD.

31.9. Summit Therapeutics Inc.

31.10. Tempus Labs Inc.

31.11. Guardant Health

31.12. NeoGenomics Laboratories Inc.

31.13. Promega Corporation

31.14. Caris Life Sciences

31.15. Owkin

32. Global MSI-H And dMMR Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The MSI-H And dMMR Market

34. Recent Developments In The MSI-H And dMMR Market

35. MSI-H And dMMR Market High Potential Countries, Segments and Strategies

35.1 MSI-H And dMMR Market In 2029 - Countries Offering Most New Opportunities

35.2 MSI-H And dMMR Market In 2029 - Segments Offering Most New Opportunities

35.3 MSI-H And dMMR Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global MSI-H And dMMR Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global MSI-H And dMMR Market, Sub-Segmentation Of Immune Checkpoint Inhibitors (ICIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global MSI-H And dMMR Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global MSI-H And dMMR Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global MSI-H And dMMR Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Pfizer Inc. Financial Performance

Table 78: F. Hoffmann-La Roche Ltd Financial Performance

Table 79: Merck & Co. Inc. Financial Performance

Table 80: AbbVie Inc. Financial Performance

Table 81: Bayer AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global MSI-H And dMMR Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global MSI-H And dMMR Market, Sub-Segmentation Of Immune Checkpoint Inhibitors (ICIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global MSI-H And dMMR Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global MSI-H And dMMR Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global MSI-H And dMMR Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, MSI-H And dMMR Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, MSI-H And dMMR Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, MSI-H And dMMR Market, Segmentation By Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Pfizer Inc. Financial Performance

Figure 78: F. Hoffmann-La Roche Ltd Financial Performance

Figure 79: Merck & Co. Inc. Financial Performance

Figure 80: AbbVie Inc. Financial Performance

Figure 81: Bayer AG Financial Performance

Top Growth Trends in the Spine Biologics Market: Insights into Market Size and Opportunities for 2025-2034

Subcutaneous Immunoglobulin (SCIG) Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

Tacrolimus Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Tetanus Toxoid Vaccine Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034

Topical Wound Agents Market Growth Outlook: Trends, Market Size, and Opportunities Over the Next Decade

Understanding Key Drivers and Growth Opportunities in the Tylosin Market: Trends and Market Size Insights

Urology Supplements Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

DNA And Gene Chip Global Market Report 2025 – By Type( Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types), By Application( Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications), By End User( Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

DNA Based Skin Care Products Global Market Report 2025 – By Product Type (Serum, Cream, Other Product Types), By End User (Home User, Wellness Clinics), By Distribution Channel (Online, Offline) – Market Size, Trends, And Global Forecast 2025-2034

View Report

DNA Digital Data Storage Global Market Report 2025 – By Sequencing (Synthesis, Ion Semiconductor, Chain Termination, Ligation, Nanopore Sequencing), By Deployment (Cloud, On-Premise), By Application (Diagnostic Research, Personalized Medicine, Other Application), By End User (Hospital, Clinics, Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

DNA Repair Drugs Global Market Report 2025 – By Drug Type (Olaparib, Rucaparib, Niraparib, Talazoparib, Other Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), By Application (Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Breast Cancer, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

DNA Sequencing Global Market Report 2025 – By Product (Instruments, Consumables, Services), By Technology (Third Generation DNA Sequencing, Next-Generation Sequencing, Sanger Sequencing), By Application (Diagnostics, Biomarkers And Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications), By End User (Hospitals And Healthcare Organizations, Academics And Research Institutions, Pharmaceutical And Biotechnology Companies, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

DNA/RNA Sample Extraction And Isolation Global Market Report 2025 – By Product (Consumables, Instruments), By Technology (Consumable-Based Technology, Instrument-Based Technology), By Application (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Cloning, Microarray, Blotting Techniques, Other Applications), By End-User (Clinical Diagnostic And Forensic Laboratories, Research Academics And Institutions, Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CRO), Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Explosive Ordnance Disposal Equipment Global Market Report 2025 – By Equipment Type (Portable X-Ray Systems, Projected Water Disrupters, Bomb Containment Chambers, EOD Suits And Blankets, EOD Robots, Explosive Detectors, Search Mirrors, Other Equipment Types ), By Technology (Trace, Bulk), By Application (Defense, Law Enforcement) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Prenatal DNA Sequencing Global Market Report 2025 – By Type (Genetic Diseases, Nonhereditary Diseases), By Application (Hemophilia, Down Syndrome, Cystic Fibrosis, Autism, DiGeorge Syndrome, AIDS (Acquired Immunodeficiency Syndrome), Cancer, Other Applications), By End User (Academic Research, Clinical Research, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the MSI H And dMMR market?

How will the MSI H And dMMR market drivers and restraints affect the market dynamics? What forces will shape the MSI H And dMMR industry going forward?

The MSI H And dMMR market major growth driver - Rising Prevalence Of Cancer Is Fueling The Market Due To Increasing Demand For Personalized Immunotherapy Approaches. For further insights on the MSI H And dMMR market, request a sample here

What is the forecast market size or the forecast market value of the MSI H And dMMR market?

The MSI H And dMMR market size has grown strongly in recent years. The MSI-H and dMMR market size has grown exponentially in recent years. It will grow from $6.15 billion in 2024 to $7.59 billion in 2025 at a compound annual growth rate (CAGR) of 23.3%. The growth in the historic period can be attributed to rising incidence of colorectal and endometrial cancers, expanded genetic screening programs, growing clinical adoption of MSI testing, increasing awareness of hereditary cancer syndromes, and a rise in liquid biopsy adoption. The MSI-H and dMMR market size is expected to see exponential growth in the next few years. It will grow to $17.40 billion in 2029 at a compound annual growth rate (CAGR) of 23.1%. The growth in the forecast period can be attributed to increasing demand for personalized cancer therapies, expanding applications of next-generation sequencing, rising healthcare expenditure in oncology, growing clinical trials for immune checkpoint inhibitors, and regulatory support for companion diagnostics. Major trends in the forecast period include the integration of artificial intelligence in diagnostic workflows, partnerships between pharma and diagnostic companies, the development of multiplex biomarker panels, advances in immunotherapy, and a shift toward pan-cancer biomarker testing. For further insights on the MSI H And dMMR market, request a sample here

How is the MSI H And dMMR market segmented?

The MSI-H and dMMR market covered in this report is segmented –
1) By Treatment Type: Immune Checkpoint Inhibitors (ICIs), Combination Therapy
2) By Indication: Endometrial, Gastric, Colorectal Cancer, Small Intestine Cancer, Cervical Cancer, Other Indications
3) By Stage: Early Stages, Advanced Stages
4) By End User: Hospitals, Oncology Clinics, Research Institutions, Homecare
Subsegments:
1) By Immune Checkpoint Inhibitors (ICIs): Programmed Cell Death Protein 1 Inhibitors, Programmed Cell Death Ligand 1 Inhibitors, Cytotoxic T-Lymphocyte Antigen 4 Inhibitors
2) By Combination Therapy: Immune Checkpoint Inhibitor + Chemotherapy, Immune Checkpoint Inhibitor + Targeted Therapy, Immune Checkpoint Inhibitor + Radiation Therapy, Immune Checkpoint Inhibitor + Other Immunotherapies For further insights on the MSI H And dMMR market, request a sample here

Which region has the largest share of the MSI H And dMMR market? What are the other regions covered in the report?

Who are the major players in the MSI H And dMMR market?

What are the key trends in the MSI H And dMMR market?

Major trends in the MSI H And dMMR market include Innovative Combination Therapies Transforming MSI-H And dMMR Cancer Treatment. For further insights on the MSI H And dMMR market, request a sample here.

What are the major opportunities in the MSI H And dMMR market? What are the strategies for the MSI H And dMMR market?

For detailed insights on the major opportunities and strategies in the MSI H And dMMR market, request a sample here.

How does the MSI H And dMMR market relate to the overall economy and other similar markets?

For detailed insights on MSI H And dMMR's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the MSI H And dMMR industry?

For detailed insights on the mergers and acquisitions in the MSI H And dMMR industry, request a sample here.

What are the key dynamics influencing the MSI H And dMMR market growth? SWOT analysis of the MSI H And dMMR market.

For detailed insights on the key dynamics influencing the MSI H And dMMR market growth and SWOT analysis of the MSI H And dMMR industry, request a sample here.

MSI-H And dMMR Global Market Report 2025

MSI-H And dMMR Global Market Report 2025

Market Insights

Related Reports

What Is Covered Under MSI-H And dMMR Market?

What Is The MSI-H And dMMR Market Size 2025 And Growth Rate?

What Is The MSI-H And dMMR Market Growth Forecast?

How Is The MSI-H And dMMR Market Segmented?

What Is Driving The MSI-H And dMMR Market? Rising Prevalence Of Cancer Is Fueling The Market Due To Increasing Demand For Personalized Immunotherapy Approaches

Who Are The Major Players In The Global MSI-H And dMMR Market?

What Are The Key Trends Of The Global MSI-H And dMMR Market? Innovative Combination Therapies Transforming MSI-H And dMMR Cancer Treatment

What Are Latest Mergers And Acquisitions In The MSI-H And dMMR Market? Owkin Inc. Partners With MSD To Enhance AI-Powered Digital Pathology Diagnostics For Cancer

What Is The Regional Outlook For The Global MSI-H And dMMR Market?

What Defines the MSI-H And dMMR Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the MSI-H And dMMR Industry?

Table Of Contents

List Of Tables

List Of Figures

Top Growth Trends in the Spine Biologics Market: Insights into Market Size and Opportunities for 2025-2034

Subcutaneous Immunoglobulin (SCIG) Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

Tacrolimus Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Tetanus Toxoid Vaccine Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034

Topical Wound Agents Market Growth Outlook: Trends, Market Size, and Opportunities Over the Next Decade

Understanding Key Drivers and Growth Opportunities in the Tylosin Market: Trends and Market Size Insights

Urology Supplements Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

DNA Based Skin Care Products Global Market Report 2025 – By Product Type (Serum, Cream, Other Product Types), By End User (Home User, Wellness Clinics), By Distribution Channel (Online, Offline) – Market Size, Trends, And Global Forecast 2025-2034

Frequently Asked Questions